Nasdaq Stockholm Welcomes Surgical Science to First North


Stockholm, June 19, 2017 — Nasdaq (Nasdaq: NDAQ) announces that the trading in Surgical Science Sweden AB’s shares (short name: SUS) commenced today on Nasdaq First North in Stockholm. Surgical Science belongs to the health care sector and is the 59th company to be admitted to trading on Nasdaq’s Nordic markets* in 2017.

Surgical Science is a supplier of virtual reality simulators for medical training. Its training systems for laparoscopy and endoscopy are used by medical training centers and institutes worldwide for practice, validation and certification of students, surgeons, and medical doctors. Surgical Science was founded in 1999 and is headquartered in Gothenburg, Sweden. For more information, please visit www.surgicalscience.com.

“We are pleased with the high degree of interest in our listing and warmly welcome the new shareholders,” said Gisli Hennermark, CEO of Surgical Science Sweden AB. “Focus now is on growth so that all surgeons entering the operating room for the first time have had the chance to train, and be objectively evaluated, in a safe simulated VR environment. Growing sales of our own products together with licencing our proprietary simulation software to medical device companies will result in safety for patients as well as value creation for shareholders.”

“We welcome Surgical Science to our European growth market, Nasdaq First North,” said Adam Kostyál, SVP and Head of European listings at Nasdaq. “Surgical Science is yet another example of an innovative company joining our health care sector, and we congratulate the company on its successful Nasdaq First North listing.”

Surgical Science Sweden AB has appointed Erik Penser Bank AB as the Certified Adviser.

*Main markets and Nasdaq First North at Nasdaq Copenhagen, Nasdaq Helsinki, Nasdaq Iceland and Nasdaq Stockholm.

 

About Nasdaq First North

Nasdaq First North is regulated as a multilateral trading facility, operated by the different exchanges within Nasdaq Nordic (Nasdaq First North Denmark is regulated as an alternative marketplace). It does not have the legal status as an EU-regulated market. Companies at Nasdaq First North are subject to the rules of Nasdaq First North and not the legal requirements for admission to trading on a regulated market. The risk in such an investment may be higher than on the main market.

About Nasdaq

Nasdaq (Nasdaq: NDAQ) is a leading global provider of trading, clearing, exchange technology, listing, information and public company services. Through its diverse portfolio of solutions, Nasdaq enables customers to plan, optimize and execute their business vision with confidence, using proven technologies that provide transparency and insight for navigating today's global capital markets. As the creator of the world's first electronic stock market, its technology powers more than 89 marketplaces in 50 countries, and 1 in 10 of the world's securities transactions. Nasdaq is home to 3,800 total listings with a market value of $11 trillion. To learn more, visit: http://business.nasdaq.com

Nasdaq Copenhagen, Nasdaq Helsinki, Nasdaq Iceland, Nasdaq Riga, Nasdaq Stockholm, Nasdaq Tallinn, Nasdaq Vilnius, Nasdaq Clearing and Nasdaq Broker Services are respectively brand names for the regulated markets of Nasdaq Copenhagen A/S, Nasdaq Helsinki Ltd., Nasdaq Iceland hf., Nasdaq Riga, AS, Nasdaq Stockholm AB, Nasdaq Tallinn AS, AB Nasdaq Vilnius, Nasdaq Clearing AB and Nasdaq Broker Services AB. Nasdaq Nordic represents the common offering by Nasdaq Copenhagen, Nasdaq Helsinki, Nasdaq Iceland and Nasdaq Stockholm. Nasdaq Baltic represents the common offering by Nasdaq Tallinn, Nasdaq Riga and Nasdaq Vilnius.

Cautionary Note Regarding Forward-Looking Statements

The matters described herein contain forward-looking statements that are made under the Safe Harbor provisions of the Private Securities Litigation Reform Act of 1995. These statements include, but are not limited to, statements about Nasdaq and its products and offerings. We caution that these statements are not guarantees of future performance. Actual results may differ materially from those expressed or implied in the forward-looking statements. Forward-looking statements involve a number of risks, uncertainties or other factors beyond Nasdaq's control. These factors include, but are not limited to factors detailed in Nasdaq's annual report on Form 10-K, and periodic reports filed with the U.S. Securities and Exchange Commission. We undertake no obligation to release any revisions to any forward-looking statements.

Media Relations Contact:
Erik Granström
+46 8 405 78 07
erik.granstrom@nasdaq.com
 

 


Attachments

20170619_Surgical Science Chairman Roland Bengtsson and CEO Gisli Hennermark.jpg